Delivery Order SPE2DB20D3101-SPE2DB23FRGA8
- Not listed
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,103.42, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 22, 2024. The contract is not designated...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,228.94 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,626.90 firm-fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,857.45 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,176.14 Firm Fixed Price Delivery Order contract is for the delivery of ZILRETTA 32 MG VIALS, a medical product, with a performance period through January 21, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a wholly owned subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $2,297.76 and is a firm fixed-price delivery order with an ultimate completion date of October 18, 2021. The contract was awarded on September 24, 2021, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,857.45 firm fixed-price delivery order is for the supply of 4567089353 ZILRETTA 32 MG VIALS, with a completion date of February 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the supply of the pharmaceutical product ZILRETTA 32 MG VIALS to the U.S. Department of Defense (DoD) and its agencies, including the Defense Logistics Agency (DLA) Troop Support Medical. The $3,505.70 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 9, 2024, with a period of performance through July 30, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,051.71 firm-fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a specialty medication. The contract has a performance period through November 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the U.S. Government. The contract, valued at $4,206.84, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price and an ultimate completion date of September 20, 2024. The contract is a delivery order and is not set aside for any particular socioeconomic category. Amerisourcebergen holds several...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRGA8Delivery Order
This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The $2,098.20 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 13, 2023 and was awarded on March 23, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order falls under that larger IDC contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 3/23/23 |